Together we will beat cancerDonate
Ovarian cancer is the 6th most common cancer in women in the UK, with 7,400 people diagnosed each year. The symptoms of ovarian cancer can be very vague, particularly when the disease is in its early stages.
New research has shown that an intelligent knife can distinguish between ovarian cancer and normal tissue. Could it help make ovarian cancer surgery smarter?
Patients are at the heart of what we do, so we asked a pancreatic cancer survivor to pick the 2017 cancer research highlights that matter to him.
This week saw new research on brain tumour and ovarian cancers, while MPs launched an inquiry into e-cigarettes.
The most aggressive type of ovarian cancer develops from cells that come from the fallopian tubes rather than the ovaries, according to a small study.
In this week’s cancer news there’s Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.
Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening.
A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.
Our scientists are looking for ways to use blood tests in cancer prognosis and treatment planning.
Scientists might be able to quickly predict how ovarian cancer patients are likely to respond to chemotherapy treatment using a simple blood test.
Find out how our new up and coming researchers plan to tackle some of the big scientific questions in cancer.